Chemed price target raised to $436 from $422 at RBC Capital

RBC Capital raised the firm’s price target on Chemed (CHE) to $436 from $422 and keeps a Sector Perform rating on the shares. Shares rallied over 10% on Friday following a solid Q1 print and a rare post-Q1 guidance raise, with VITAS delivering strong census growth and margin outperformance that drove consolidated EBITDA and EPS well above consensus, the analyst tells investors in a research note.